Switch theme
Sign up to access all valuation multiples
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
2006
66
LTM Revenue $4.2M
LTM EBITDA n/a
$60.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Icecure Medical has a last 12-month revenue of $4.2M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Icecure Medical achieved revenue of $3.3M and an EBITDA of -$15.4M.
Icecure Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Icecure Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $3.2M | $3.3M | XXX | XXX | XXX |
| Gross Profit | $1.4M | $1.3M | XXX | XXX | XXX |
| Gross Margin | 45% | 40% | XXX | XXX | XXX |
| EBITDA | -$15.3M | -$15.4M | XXX | XXX | XXX |
| EBITDA Margin | -472% | -467% | XXX | XXX | XXX |
| Net Profit | -$17.0M | -$14.7M | XXX | XXX | XXX |
| Net Margin | -526% | -445% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Icecure Medical's stock price is $1.
Icecure Medical has current market cap of $68.0M, and EV of $60.9M.
See Icecure Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $60.9M | $68.0M | XXX | XXX | XXX | XXX | $-0.29 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Icecure Medical has market cap of $68.0M and EV of $60.9M.
Icecure Medical's trades at 14.6x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Icecure Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Icecure Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $60.9M | XXX | XXX | XXX |
| EV/Revenue | 18.5x | XXX | XXX | XXX |
| EV/EBITDA | -4.0x | XXX | XXX | XXX |
| P/E | -4.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIcecure Medical's NTM/LTM revenue growth is 140%
Icecure Medical's revenue per employee for the last fiscal year averaged $50K, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Icecure Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Icecure Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Icecure Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -467% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -327% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $50K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 35% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 271% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 216% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 521% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Icecure Medical acquired XXX companies to date.
Last acquisition by Icecure Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Icecure Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Icecure Medical founded? | Icecure Medical was founded in 2006. |
| Where is Icecure Medical headquartered? | Icecure Medical is headquartered in United States of America. |
| How many employees does Icecure Medical have? | As of today, Icecure Medical has 66 employees. |
| Who is the CEO of Icecure Medical? | Icecure Medical's CEO is Mr. Eyal Shamir. |
| Is Icecure Medical publicy listed? | Yes, Icecure Medical is a public company listed on NAS. |
| What is the stock symbol of Icecure Medical? | Icecure Medical trades under ICCM ticker. |
| When did Icecure Medical go public? | Icecure Medical went public in 2013. |
| Who are competitors of Icecure Medical? | Similar companies to Icecure Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Icecure Medical? | Icecure Medical's current market cap is $68.0M |
| What is the current revenue of Icecure Medical? | Icecure Medical's last 12-month revenue is $4.2M. |
| What is the current EV/Revenue multiple of Icecure Medical? | Current revenue multiple of Icecure Medical is 14.6x. |
| What is the current revenue growth of Icecure Medical? | Icecure Medical revenue growth between 2023 and 2024 was 2%. |
| Is Icecure Medical profitable? | Yes, Icecure Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
